Marc Hedrick
Company: Plus Therapeutics
Job title: CEO
Seminars:
Re-186 Radiolabelled NanoLiposomes for Rare Brain and Spinal Cord Tumors 1:00 pm
• Exploring preclinical & clinical (Phase 1, Phase 2) data • Applying this to notoriously-difficult to treat recurrent glioblastoma • How effective is this for treating pediatric ependymoma & high-grade gliomasRead more
day: Day 1 - Track A (PM)